GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
1.38
-0.11 (-7.07%)
At close: Aug 19, 2025, 10:28 AM
-7.07% (1D)
| Bid | 1.47 |
| Market Cap | 4.34M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.67M |
| EPS (ttm) | -3.98 |
| PE Ratio (ttm) | -0.35 |
| Forward PE | -1.75 |
| Analyst | Buy |
| Ask | 1.51 |
| Volume | 45,615 |
| Avg. Volume (20D) | 94,096 |
| Open | 1.48 |
| Previous Close | 1.49 |
| Day's Range | 1.35 - 1.48 |
| 52-Week Range | 0.96 - 4.10 |
| Beta | 1.33 |
About GTBP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GTBP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GTBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
-7.59%
GT Biopharma shares are trading lower. The company...
Unlock content with
Pro Subscription
5 months ago
+21.18%
GT Biopharma shares are trading higher after the company announced a request for the withdrawal of form S-1 registration with the SEC.
